Your browser doesn't support javascript.
loading
Generation of vascular chimerism within donor organs.
Cohen, Shahar; Partouche, Shirly; Gurevich, Michael; Tennak, Vladimir; Mezhybovsky, Vadym; Azarov, Dmitry; Soffer-Hirschberg, Sarit; Hovav, Benny; Niv-Drori, Hagit; Weiss, Chana; Borovich, Adi; Cohen, Guy; Wertheimer, Avital; Shukrun, Golan; Israeli, Moshe; Yahalom, Vered; Leshem-Lev, Dorit; Perl, Leor; Kornowski, Ran; Wiznitzer, Arnon; Tobar, Ana; Feinmesser, Meora; Mor, Eytan; Atar, Eli; Nesher, Eviatar.
Afiliação
  • Cohen S; Laboratory for Organ Bioengineering, Rabin Medical Center, Petah Tikva, Israel. shaharco@gmail.com.
  • Partouche S; Laboratory for Organ Bioengineering, Rabin Medical Center, Petah Tikva, Israel.
  • Gurevich M; Felsenstien Medical Research Center, Rabin Medical Center, Petah Tikva, Israel.
  • Tennak V; Department of Organ Transplantation, Rabin Medical Center, Petah Tikva, Israel.
  • Mezhybovsky V; Department of Organ Transplantation, Rabin Medical Center, Petah Tikva, Israel.
  • Azarov D; Department of Organ Transplantation, Rabin Medical Center, Petah Tikva, Israel.
  • Soffer-Hirschberg S; Experimental Surgery Unit, Rabin Medical Center, Petah Tikva, Israel.
  • Hovav B; Department of Radiology, Rabin Medical Center, Petah Tikva, Israel.
  • Niv-Drori H; Department of Radiology, Rabin Medical Center, Petah Tikva, Israel.
  • Weiss C; Department of Pathology, Rabin Medical Center, Petah Tikva, Israel.
  • Borovich A; Department of Pathology, Rabin Medical Center, Petah Tikva, Israel.
  • Cohen G; Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel.
  • Wertheimer A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Shukrun G; Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel.
  • Israeli M; Helen Schneider Hospital for Women, Rabin Medical Center, Petah Tikva, Israel.
  • Yahalom V; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Leshem-Lev D; Division of Pediatric Cardiothoracic Surgery, Schneider Children's Medical Center, Petah Tikva, Israel.
  • Perl L; Department of Cardiothoracic Surgery, Rabin Medical Center, Petah Tikva, Israel.
  • Kornowski R; Tissue Typing Laboratory, Rabin Medical Center, Petah Tikva, Israel.
  • Wiznitzer A; Zefat Academic College, Zefat, Israel.
  • Tobar A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Feinmesser M; Blood Services and Apheresis Institute, Rabin Medical Center, Petah Tikva, Israel.
  • Mor E; Felsenstien Medical Research Center, Rabin Medical Center, Petah Tikva, Israel.
  • Atar E; Department of Cardiology, Rabin Medical Center, Petah Tikva, Israel.
  • Nesher E; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sci Rep ; 11(1): 13437, 2021 06 28.
Article em En | MEDLINE | ID: mdl-34183759
Whole organ perfusion decellularization has been proposed as a promising method to generate non-immunogenic organs from allogeneic and xenogeneic donors. However, the ability to recellularize organ scaffolds with multiple patient-specific cells in a spatially controlled manner remains challenging. Here, we propose that replacing donor endothelial cells alone, while keeping the rest of the organ viable and functional, is more technically feasible, and may offer a significant shortcut in the efforts to engineer transplantable organs. Vascular decellularization was achieved ex vivo, under controlled machine perfusion conditions, in various rat and porcine organs, including the kidneys, liver, lungs, heart, aorta, hind limbs, and pancreas. In addition, vascular decellularization of selected organs was performed in situ, within the donor body, achieving better control over the perfusion process. Human placenta-derived endothelial progenitor cells (EPCs) were used as immunologically-acceptable human cells to repopulate the luminal surface of de-endothelialized aorta (in vitro), kidneys, lungs and hind limbs (ex vivo). This study provides evidence that artificially generating vascular chimerism is feasible and could potentially pave the way for crossing the immunological barrier to xenotransplantation, as well as reducing the immunological burden of allogeneic grafts.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Heterólogo / Quimeras de Transplante / Engenharia Tecidual / Células Endoteliais / Medicina Regenerativa / Alicerces Teciduais Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Heterólogo / Quimeras de Transplante / Engenharia Tecidual / Células Endoteliais / Medicina Regenerativa / Alicerces Teciduais Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Israel
...